Doxazosin--an alpha-1 receptor blocking agent in the long-term management of benign prostatic hyperplasia (BPH) (Part Two)
- PMID: 8586513
- DOI: 10.1007/BF02550076
Doxazosin--an alpha-1 receptor blocking agent in the long-term management of benign prostatic hyperplasia (BPH) (Part Two)
Abstract
This part of our study presents results of laboratory evaluations in patients with BPH during treatment with prazosin and doxazosin. After 72 weeks serum PSA and PAP fell by 40.2% and 82%, respectively. Blood urea nitrogen concentration decreased by 28.5% and serum creatinine by 20.8%. The results confirm long-term favourable effects of the therapy of patients with BPH.
Similar articles
-
Doxazosin--an alpha-1 receptor blocking agent in the long-term management of benign prostatic hyperplasia (Part One).Int Urol Nephrol. 1995;27(3):311-8. doi: 10.1007/BF02564768. Int Urol Nephrol. 1995. PMID: 7591596 Clinical Trial.
-
Serum PSA levels at 6 month after surgery, TURP or Doxazosin therapy for BPH.Mater Med Pol. 1996 Apr-Jun;28(2):69-70. Mater Med Pol. 1996. PMID: 9088130 Clinical Trial.
-
Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance.J Urol. 2003 Apr;169(4):1520-5. doi: 10.1097/01.ju.0000033280.29453.72. J Urol. 2003. PMID: 12629407 Review.
-
Doxazosin for benign prostatic hyperplasia in primary care.Clin Ther. 1997 Nov-Dec;19(6):1269-77; discussion 1253-4. doi: 10.1016/s0149-2918(97)80004-5. Clin Ther. 1997. PMID: 9444439 Review.
-
A comparative study of: long-term alpha-1-blocker, Doxazosin therapy versus surgery in the treatment of benign prostatic hyperplasia.Mater Med Pol. 1995 Oct-Dec;27(4):151-2. Mater Med Pol. 1995. PMID: 9000839 Clinical Trial.
Cited by
-
Efficacy and tolerability of drugs for treatment of benign prostatic hyperplasia.Int Urol Nephrol. 2001;32(3):423-32. doi: 10.1023/a:1017595818158. Int Urol Nephrol. 2001. PMID: 11583366
-
Long-term treatment with doxazosin in men with benign prostatic hyperplasia: 10-year follow-up.Int Urol Nephrol. 2004;36(2):169-73. doi: 10.1023/b:urol.0000034688.65087.18. Int Urol Nephrol. 2004. PMID: 15368687 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous